Cervarix HPV jab Deaths and Injuries caused by Endotoxin Lipid A

GSK Human Papilloma Virus jab Cervarix contains E. coli Endotoxin as adjuvant which can explain all the tragic outcomes.

Children have been killed and maimed by Cervarix jab which is composed of recombinant C-terminally truncated HPV-16 L1 and HPV-18 L1 proteins (20 micrograms each) in virus-like particles (VLPs) adjuvanted with AS04 adjuvant system, composed of an Aluminium Hydroxide Al(OH)3 (500 micrograms) and 3-O-desacyl-4'-MonoPhosphoryl Lipid A (MPL, 50 micrograms).

The HPV-16 and HPV-18 L1 antigens are prepared by recombinant DNA technology using a Baculovirus expression system in Trichoplusia ni cells.¹

Cervarix also contains Sodium Chloride (NaCl, salt 4.4 mg), monobasic Sodium Phosphate (NaH2PO4.2 H2O, 624 micrograms) and water for injection.

MPL MonoPhosphoryl Lipid A from E. coli Bacteria

Cervarix contains deliberately added supertoxin MPL derived from E. coli. It differs from ordinary supertoxin Lipid A by deletion of a single Phosphate group.

MPL has ludicrously been described as a “detoxified” form of Endotoxin Lipid A and was the first such molecule to be approved in a jab as adjuvant. Read more about the madness.²

Gene Interactions of MPL

MPL causes increased expression of mRNA or protein by action on the following genes:

CALCA mRNA; CAT protein; HMOX1 mRNA; ICAM1 protein; IFNG protein; IL1B protein; IL6 protein; IL12 protein; IL17A protein; IL18 protein; IL22 protein; NFKBIA protein; NOTCH1 mRNA; RELA protein; SELE protein; TLR4 protein; TNF protein; VCAM1 protein

Many readers have a special interest in the above list, so I will expand on some of them later.

Diseases caused by MPL

The US government Comparative Toxicogenomics database is once again a useful guide with 425 Diseases listed with peer-reviewed papers.³

It needs some extra curation, but 80 detailed biochemical pathways for its action have been posted already based on inference from the parent Lipid A.⁴

Australia DAEN reports

TGA Australia shows a number of systemic Adverse Event reports for Cervarix, all consistent with the Endotoxin.⁵ The Aluminium causes less immediate reactions, but is of course a Neurotoxin adding to Alzheimer’s and related diseases in later life.

LNP packaging of MPL increases the Damage

Incorporation of MPL in PLGA (poly(lactic-co-glycolic acid) Nanoparticles increases T_H1 and pro-inflammatory responses of the Target Dendritic Cells (DCs) in comparison to the non-encapsulated administration of MPL.⁶

In general the use of Cationic LNPs carrying reactogenic adjuvant is the same approach used for the mRNA jabs⁷, i.e. deliberate harm induction by attack on DCs, as shown by Figure 1 from Nagy and coworkers.

This Figure is also useful as it gives a fairly accurate idea of the relative size of the DCs (about 10,000 nm) to the LNPs (typically 80 nm).

Arexvy Jab contains Endotoxin MPL

A recent article by Sherri Tenpenny alerts us to another high risk jab from GSK.⁸ Arexvy is supposed to target Respiratory Syncytial Virus (RSV).

Sherri tells us:

When the two vials are mixed together (reconstituted) each 0.5cc dose contains:

• RSVPreF3 antigen                   120 mcg

• MPL                                             25 mcg

• QS-21  from (tree bark)              25 mcg

• Trehalose                              14,700 mcg

• Sodium Chloride (salt)         4,400 mcg

• Potassium dihydrogen phosphate 830 mcg

• Dipotassium phosphate           260 mcg

• Polysorbate 80                        180 mcg

• Disodium phosphate anhydrous 150 mcg

• DOPC (lipids in lysosome)      500 mcg

• Cholesterol                                125 mcg

November Update

Lots of useful information including free downloads has been kindly provided on HPV jabs.⁹

I expect a number of people would like to contribute useful information in the comments when they hear of the massive Lipid A content compared to the Covid19 jabs. You can help me add to the data and reference list.

Paid subscriptions are much appreciated.

1. Human Papillomavirus Vaccine Types 16 and 18 (Recombinant, AS04 adjuvanted). TGA Product Information. July 2023

2.

3. https://ctdbase.org/detail.go?acc=C048436&view=disease&sort=diseaseNmSort&type=chem&dir=asc

4. https://ctdbase.org/detail.go?acc=C048436&view=pathway&sort=pathwayAccFull&page=1&type=chem&dir=asc

5. https://daen.tga.gov.au/medicines-search/

6. Nagy NA, et al. 2021. Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance. https://www.frontiersin.org/articles/10.3389/fimmu.2021.674048/full

7.

8. The Next Billion Dollar Vaccine Deal, Part 1

9. HPV Vaccine